Some questions about preadmission metformin use and mortality in patients with sepsis and diabetes mellitus - PubMed (original) (raw)
Comment
Some questions about preadmission metformin use and mortality in patients with sepsis and diabetes mellitus
Jiarong Ye et al. Crit Care. 2019.
No abstract available
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comment in
- Response.
Liang H, Ding X, Sun T. Liang H, et al. Crit Care. 2019 May 20;23(1):181. doi: 10.1186/s13054-019-2458-x. Crit Care. 2019. PMID: 31109369 Free PMC article. No abstract available.
Comment on
- Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.
Liang H, Ding X, Li L, Wang T, Kan Q, Wang L, Sun T. Liang H, et al. Crit Care. 2019 Feb 18;23(1):50. doi: 10.1186/s13054-019-2346-4. Crit Care. 2019. PMID: 30777119 Free PMC article.
References
- Liang H, Ding X, Li L, Wang T, Kan Q, Wang L, et al. Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Critical Care (London, England) 2019;23(1):50. doi: 10.1186/s13054-019-2346-4. - DOI - PMC - PubMed
- Kushimoto S, Gando S, Saitoh D, Mayumi T, Ogura H, Fujishima S, et al. Impact of serum glucose levels on disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. Acute Med Surg. 2015;2(1):21–28. doi: 10.1002/ams2.59. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical